Results 231 to 240 of about 9,923,027 (411)

Multivariate Screening and Automated Clustering of Macrophage Immunoreactome to Nanoparticles and Photothermal Therapy

Advanced Science, EarlyView.
Predicting immune responses to treatments, including nanomedicines, with high throughput test is challenging due to the immunoreactome's complexity and plasticity. A predictive screening platform integrating pathway activation and gene profiling in macrophages has been developed as a versatile tool for designing effective immunotherapies.
Sonia Becharef, Léa Jabbour, Nassima Bekaddour, Giulio Avveduto, Nathalie Luciani, Gautier Laurent, Rana Bazzi, Edouard Alphandery, Stéphane Roux, Amanda K. A. Silva, Kelly Aubertin, Jean‐Philippe Herbeuval, Florence Gazeau   +12 more
wiley   +1 more source

Immune-regulating extracellular vesicles: a new frontier in autoimmune disease therapy. [PDF]

Essays Biochem
Shah H, Liu Z, Guo W, Ren W, Xiao Y.
europepmc   +1 more source

Autoimmune thyroid disease and pregnancy. [PDF]

, 1984
Anthony McGregor, R. Hall, C. Richards
openalex   +1 more source

Bilirubin Targeting WNK1 to Alleviate NLRP3‐Mediated Neuroinflammation

Advanced Science, EarlyView.
At physiological concentrations, bilirubin binds to the kinase domain of WNK1, thereby augmenting its activity and facilitating the phosphorylation of downstream SPAK/OSR1. This phosphorylation inhibits KCC2 activity, leading to elevate intracellular chloride levels in neurons.
Linfei Mao, Jiayu Lu, Quanjun Yang, Zhenqi Liu, Cuiping Wu, Bingbing Ke, Kaiyan Su, Haolin Yuan, Yaqi Cui, Yao Wang, Richard Salvi, Guang Yang, Shankai Yin, Feng Liu, Chunyan Li   +14 more
wiley   +1 more source

Sleep and circadian disorders as risk factors for autoimmune disease: A population-based study. [PDF]

Neurobiol Sleep Circadian Rhythms
Li AR, Shah B, Thomas ML, McCarthy MJ, Meruelo AD.   +4 more
europepmc   +1 more source

Sialochemistry of patients with autoimmune rheumatic disease with and without histological manifestations of Sjogren's syndrome.

, 1985
E B Tsianos, Athanasios G. Tzioufas, Anestis Mavridis, A K Sarras, Constantinos Papadimitriou, Orestes Tsolas, H M Moutsopoulos   +6 more
openalex   +1 more source

Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P1) and receptor‐5 (S1P5) agonist with autoimmune disease‐modifying activity

British Journal of Pharmacology, 2016
F. Scott, B. Clemons, J. Brooks, E. Brahmachary, R. Powell, H. Dedman, H. Desale, G. Timony, E. Martinborough, H. Rosen, E. Roberts, M. Boehm, R. Peach   +12 more
semanticscholar   +1 more source

Rational Design of Inner Ear Drug Delivery Systems

Advanced Science, EarlyView.
Hearing loss is a common disease affecting many people, and inner ear lesions are one of the most important causes. This review focuses on the treatment of inner ear hearing loss by drug delivery systems. It includes the current methods and technologies developed, and it predicts possible directions.
Xiayidan Maimaitikelimu, Zhiyan Xuan, Haoyu Ren, Keng Chen, Hui Zhang, Huan Wang   +5 more
wiley   +1 more source

Hidden face of Parkinson's disease: Is it a new autoimmune disease? [PDF]

Neural Regen Res
Jo MG, Kim SH, Yun SP.
europepmc   +1 more source

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

Nature, 2003
H. Ueda, J. Howson, L. Esposito, J. Heward, H. Snook, Giselle Chamberlain, Daniel B. Rainbow, K. Hunter, Annabel N. Smith, G. Di Genova, M. Herr, I. Dahlman, F. Payne, D. Smyth, C. Lowe, R. Twells, S. Howlett, B. Healy, S. Nutland, H. Rance, Vincent H. Everett, L. Smink, A. Lam, H. Cordell, N. Walker, C. Bordin, John S Hulme, C. Motzo, F. Cucca, J. Hess, M. Metzker, J. Rogers, S. Gregory, A. Allahabadia, R. Nithiyananthan, E. Tuomilehto-Wolf, J. Tuomilehto, P. Bingley, K. Gillespie, D. Undlien, K. Rønningen, C. Guja, C. Ionescu-Tîrgoviste, D. Savage, A. Maxwell, D. Carson, C. Patterson, J. Franklyn, D. Clayton, L. Peterson, L. Wicker, J. Todd, S. Gough   +52 more
semanticscholar   +1 more source